Examination of Trends in Multiple Myeloma Trial Patient Experiences
Not yet recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- NCT05860179
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited.
This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested.
Data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future multiple myeloma patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Patient has been diagnosed with multiple myeloma
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion Criteria
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
- Pregnant, breastfeeding or expecting to conceive within the projected duration of the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of participants with multiple myeloma who decide to enroll in clinical trial 3 Months Rate of patients with multiple myeloma who remain in clinical trial to completion 12 month
- Secondary Outcome Measures
Name Time Method